Purpose: To report the development of an optical neuropathy after injection of type A botulinic toxin in a subject with blepharospasm. Methods: Optical neuropathy was evaluated through study of visual sharpness, colour test, visual field, OCT, fluorangiography and determination of VEPs. Results: Venous steroid treatment and neuro-protectors (Vitamin B6 and Citicoline) led to resolution of the clinical picture. Conclusions: The authors draw attention to the need for correct administration of the botulinic toxin in the treatment of blepharospasm.
Morreale Bubella, R., Vadalà, M., Morreale Bubella, D. (2014). Optic neuropathy caused by type A botulinic toxin. ACTA OPHTHALMOLOGICA, 92(92), 0-0 [10.1111].
Optic neuropathy caused by type A botulinic toxin
MORREALE BUBELLA, Raffaella;VADALA', Maria;
2014-01-01
Abstract
Purpose: To report the development of an optical neuropathy after injection of type A botulinic toxin in a subject with blepharospasm. Methods: Optical neuropathy was evaluated through study of visual sharpness, colour test, visual field, OCT, fluorangiography and determination of VEPs. Results: Venous steroid treatment and neuro-protectors (Vitamin B6 and Citicoline) led to resolution of the clinical picture. Conclusions: The authors draw attention to the need for correct administration of the botulinic toxin in the treatment of blepharospasm.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.